You Position: Home > Paper
CA125、CA15-3及CA19-9联检对卵巢癌诊断的价值
( views:129, downloads:20 )
- Author:
- No author available
- Journal Title:
- JOURNAL OF RADIOIMMUNOLOGY
- Issue:
- 6
- DOI:
- 10.3969/j.issn.1008-9810.2013.06.073
- Key Word:
- No keyword available
Abstract： @@ 本文通过对卵巢癌患者血清CA125、CA15-3及CA19-9浓度的检测及分析,评估单独及联检对卵巢癌诊断性能,为临床诊断提供依据.
- [1]曹冬焱,沈铿,陶陶,等.卵巢交界性黏液性肿瘤130例临床病理分析[J].2011,(1).
- [2]郑航,罗荣城.TPS、CA-153和CEA联合检测对乳腺癌的诊断价值[J].2005,(10).
- [3]陈晨,李俊东,黄鹤,等.肿瘤标志物检测对卵巢成熟、未成熟畸胎瘤的诊断价值[J].2008,(1).
- [4]Shah,C.,Berg,C.D.,O'Briant,K.,etc.Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule[J].2013,31(3).
- [5]V, Manolov,B, Marinov,V, Vasilev.[HE4 and CA125 in ovarian cancer].[J].2012,51(2).